TTFA-Platin Conjugate: Deciphering the Therapeutic Roles of Combo-Prodrug through Evaluating Stability–Activity Relationship
Journal of Medicinal Chemistry · 2024
DOI: 10.1021/acs.jmedchem.4c01545 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Megha Biswas und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Novel Materials for Sensor of Zhejiang Province College of Materials and Environmental Engineering, Hangzhou Dianzi University, Han…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Organoplatinum Compounds, Prodrugs. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 73 Literaturangaben. Gefördert von: Science and Engineering Research Board.
Abstract (Originalsprache)
This work introduces a novel Pt(II) based prodrug TTFA-Platin that integrates a β-diketonate ligand TTFA with a platinum scaffold to structurally resemble carboplatin and offers intermediate kinetic lability between cisplatin and carboplatin, striking a balance between therapeutic efficacy and safety. A comprehensive stability and speciation study was conducted in various biological media, mapping the therapeutic effects of TTFA-Platin. A control molecule, TMK-Platin, was synthesized to further validate the structural-stability relationship, which displayed poor activatable features in biological systems. In vitro studies against a panel of cancer cell lines revealed that TTFA-Platin exhibited significantly higher potency compared to TMK-Platin. In vivo studies revealed that TTFA-Platin exhibited significantly lower toxicity than the reference platinum compounds. Thus, leveraging ligands that fine-tune kinetic lability and offer therapeutic benefits can help develop more effective and safer cancer treatments, addressing the limitations of existing therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Novel Materials for Sensor of Zhejiang Province College of Materials and Environmental Engineering, Hangzhou Dianzi University, Hangzhou 310018, China.
- School of Chemical Sciences, National Institute of Science Education and Research (NISER), Bhubaneswar 752050, India.
- Roland Institute of Pharmaceutical Sciences, Berhampur 760010, Odisha, India.
ORCID-Profile: Sateesh Bandaru, Chandra Shekhar Purohit, Rakesh Kumar Pathak
Förderung
- Science and Engineering Research Board
Zitieren
APA
Biswas, M., Chaudhary, K., Padhi, S. S., Banerjee, A., Bharathavikru, R. S., Bandaru, S., Panda, S. J., Purohit, C. S., Das, N. R., & Pathak, R. K. (2024). TTFA-Platin Conjugate: Deciphering the Therapeutic Roles of Combo-Prodrug through Evaluating Stability–Activity Relationship. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c01545
Vancouver
Biswas M, Chaudhary K, Padhi SS, Banerjee A, Bharathavikru RS, Bandaru S, et al. TTFA-Platin Conjugate: Deciphering the Therapeutic Roles of Combo-Prodrug through Evaluating Stability–Activity Relationship. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c01545
BibTeX
@article{Biswas2024,
author = {Biswas, Megha and Chaudhary, Kanishka and Padhi, Swati Shree and Banerjee, Arka and Bharathavikru, R Selvi and Bandaru, Sateesh and Panda, Subhra Jyoti and Purohit, Chandra Shekhar and Das, Nihar Ranjan and Pathak, Rakesh Kumar},
title = {TTFA-Platin Conjugate: Deciphering the Therapeutic Roles of Combo-Prodrug through Evaluating Stability–Activity Relationship},
journal = {Journal of Medicinal Chemistry},
year = {2024},
doi = {10.1021/acs.jmedchem.4c01545}
}
EUVIMED